Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS)

NIAID funds CTU and their associated CRS to implement the clinical research plans of one or more of the five NIAID-funded HIV/AIDS Clinical Trials Networks.

The HIV/AIDS Clinical Trials Networks and their CTU/CRS pursue clinical trials to address NIAID’s five HIV/AIDS scientific priorities, including: 1) therapeutics for HIV/AIDS and HIV-associated infections in adults (including HIV cure, as well as co-occurring noninfectious and infectious diseases, including hepatitis and tuberculosis), 2) HIV/AIDS and HIV-associated infections in children and mothers, 3) integrated strategies to prevent HIV infection, 4) vaccines to prevent HIV infection, and 5) microbicides to prevent HIV infection.

Last Updated April 04, 2014

Last Reviewed April 12, 2010